MAP3K5 and hypertensive disorder: Meijles at al. [80] has recently shown that ASK1 inhibitors protect the heart from hypertension-induced cardiac remodeling, demonstrating the potential use of ASK1 inhibition in the treatment of hypertensive heart disease.